• Blog
  • Parenteral Nutrition Market | 2021-2026

    Parenteral Nutrition Market | 2021-2026

    Parenteral Nutrition Market | 2021-2026
    Report code - SR1419 Delivery - 2 Weeks
    Get Free Sample |
    Parenteral Nutrition Market Size, Share, Trends, Forecast, and Growth Opportunit See more...

    Insights

    "The Parenteral Nutrition Market is projected to grow from USD 5.9 billion in 2020 to USD 8.1 billion by 2026 at a CAGR of around 5.6% during 2021-26."

    Parenteral-Nutrition-Market-Forecast

    Wish to get a free sample? Register Here

    What is parenteral nutrition?

    Parenteral nutrition is defined because the feeding of nutritional products through veins to patients who don't seem to be able to eat enough food to keep up the great nutritional requirement of the body and private growth. Nutrients include carbohydrates, minerals, fat, vitamins, and other trace elements. These nutrients are delivered either peripherally or centrally, through superior vena cava.

    Drivers

    The parenteral nutrition market growth is driven by:

    • Increasing prevalence of chronic diseases due to changing lifestyles and unhealthy eating habits.
    • Expanding the geriatric populace across geographies.
    • The presence of many malnourished children and a high natality rate.
    • Rising demand for new product development is likely to create lucrative opportunities for the companies operating in the global market.

    Key Players

    Key players operating in the global Parenteral Nutrition market are-

    Segments Analysis

    By Type,

    • The market has been bifurcated into premature infants, neonates and children, geriatrics, and chronic disease patients.
    • The premature infants, neonates, and children segment accounted for the largest market share in 2020 and is projected to register significant growth during 2021-2026.

    By Region,

    “North America holds the largest market share in 2020 and is projected to grow at a significant CAGR during 2021-2026.”

    • The segment growth is primarily attributed to the presence of advanced healthcare facilities coupled with the increasing prevalence of chronic diseases.
    • The market growth in the Asia-Pacific region is expected to be driven by growing healthcare expenditure and increasing incidences of fatalities due to malnutrition.

    Covid-19 Impact

    The outbreak of the COVID-19 virus has affected the growth of the healthcare industry significantly. Stringent lockdown measures and restricted movement of people affected the product supply. However, the demand for vitamins increased to boost immunity.

    Target Audience

    Here is the list of the group of customers that the parenteral nutrition market hopes to have the greatest opportunity to convert-

    • Distributors
    • Suppliers
    • Manufacturers
    • Logistics organizations
    • Government bodies

    Research Methodology

    • This report offers high-quality insights and is the outcome of detailed research methodology comprising extensive secondary research, rigorous primary interviews with industry stakeholders and validation and triangulation with Stratview Research’s internal database and statistical tools.
    • More than 1,000 authenticated secondary sources, such as company annual reports, fact book, press release, journals, investor presentation, white papers, patents, and articles have been leveraged to gather the data.
    • We conducted more than 10 detailed primary interviews with the companies across the value chain in all four regions and with industry experts to obtain both the qualitative and quantitative insights.

    Report Features

    This report provides intelligence in the most comprehensive way. The report structure has been kept such that it offers maximum business value. It provides critical insights into the dynamics and will enable strategic decision making for the existing players as well as those willing to enter the market.

    The following are the key features of the report:

    • Overview, industry life cycle analysis, supply chain analysis
    • Environment analysis: Growth drivers and constraints, Porter’s five forces analysis, SWOT analysis
    • Trend and forecast analysis
    • Segment trend and forecast
    • Competitive landscape and dynamics: Market share, product portfolio, Technology launches, etc.
    • Attractive segments and associated growth opportunities
    • Emerging trends
    • Strategic growth opportunities for the existing and new players
    • Key success factors

    Report Customization

    With this detailed report, Stratview Research offers one of the following free customization options to our respectable clients:

    Company Profiling

    • Detailed profiling of additional market players (up to 3 players)
    • SWOT analysis of key players (up to 3 players)

    Segmentation

    • Current market segmentation of any one of the Application types & by type.  

    Competitive Benchmarking

    • Benchmarking of key players on the following parameters: Technology portfolio, geographical reach, regional presence, and strategic alliances

    Custom Research: Stratview Research offers custom research services across sectors. In case of any custom research requirement related to market assessment, competitive benchmarking, sourcing and procurement, target screening, and others, please send your inquiry to sales@stratviewresearch.com.

    Scope & Segmentation

    Parenteral Nutrition Market Features

    Base Year of Study

    2020

    Trend Period

    2015-2019

    Forecast Period

    2021-2026

    Dominant Region

    North America

    Market Size in 2026

    USD 8.1 billion

    Market Size in 2020

    USD 5.9 billion

    Growth (2021-2026)

    5.6% CAGR

    Segments Covered

    Type (Carbohydrates, Parenteral Lipid Emulsion, Single Dose Amino Acid Solution, Trace Elements, Vitamins, and Minerals), Application (Premature Infants, Neonates and Children, Geriatrics, Chronic Disease Patients), and Region.

    Key Companies

    • Baxter International Inc. (US)
    • Hospira (US)
    • B. Braun (Germany)
    • Grifols International, S.A. (Spain)
    • Fresenius Kabi (Germany)
    • Otsuka Pharmaceutical Factory, Inc. (Japan)
    • Actavis Generics (US)
    • Sichuan Kelun Pharmaceutical Co., Ltd (China).

     

    Growth Drivers

    • Increasing prevalence of chronic diseases due to changing lifestyles and unhealthy eating habits.
    • Expanding the geriatric populace across geographies.
    • The presence of many malnourished children and a high natality rate.
    • Rising demand for new product development is likely to create lucrative opportunities for the companies operating in the global market.

     

    Frequently Asked Questions (FAQs)

    The parenteral nutrition market is expected to grow at an impressive CAGR of 5.6% in the coming years.

    The premature infants, neonates, and children segment is expected to register significant growth in the parenteral nutrition market in the coming years.

    Baxter International Inc. (US), Hospira (US), B. Braun (Germany), Grifols International, S.A. (Spain), Fresenius Kabi (Germany), Otsuka Pharmaceutical Factory, Inc. (Japan), Actavis Generics (US) and Sichuan Kelun Pharmaceutical Co., Ltd (China) are among the key players in the parenteral nutrition market.

    The parenteral nutrition market size is expected to reach USD 8.1 billion in the foreseeable future.

    North America accounted for the largest share in the parenteral nutrition market in 2020.

    Parenteral nutrition distributors, Parenteral nutrition suppliers, Parenteral nutrition manufacturers, Logistics organizations, Government bodies are among the target audience in the parenteral nutrition market.